Search

Aldeyra Therapeutics Inc

Закрыт

1.35

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.34

Макс.

1.3599999999999999

Ключевые показатели

By Trading Economics

Доход

-2M

-5.5M

Прибыль на акцию

-0.16

Сотрудники

6

EBITDA

-2.5M

-5.4M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+47.06% upside

Дивиденды

By Acuity

Следующий отчет о доходах

3 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-4.2M

88M

Предыдущая цена открытия

1.35

Предыдущая цена закрытия

1.35

Aldeyra Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

20 сент. 2026 г., 23:51 UTC

BoJ Meeting Minutes on September 27 Expected to Influence Japan's Interest Rate Outlook Amid Global Economic Uncertainties.

20 сент. 2026 г., 23:11 UTC

PBOC Holds Loan Prime Rate Steady at 3.00% Amid Economic Caution and Mixed Signals in China

20 сент. 2026 г., 23:01 UTC

Macro News
Correlated Moves

The Dow Jones Index is advancing as the People's Bank of China maintains its Loan Prime Rates amid cautious market conditions and geopolitical tensions.

20 сент. 2026 г., 23:01 UTC

Correlated Moves
Macro News

The S&P 500 Index is advancing amid macroeconomic developments, including China's unchanged Loan Prime Rates and mixed industrial production and retail sales data.

20 сент. 2026 г., 23:01 UTC

Macro News
Correlated Moves

The Nasdaq 100 Index is advancing, supported by the Russell 2000's rise and the People's Bank of China's decision to maintain its Loan Prime Rate at 3.00%.

20 сент. 2026 г., 23:01 UTC

Correlated Moves
Macro News

The Russell 2000 Index is modestly higher, reflecting a stable market backdrop amid China's unchanged Loan Prime Rate and geopolitical tensions.

20 сент. 2026 г., 23:00 UTC

Macro News

Oil (WTI) is advancing amid heightened geopolitical tensions following Houthi attacks in Saudi Arabia and ongoing U.S. energy policy discussions, despite earlier session pullbacks.

20 сент. 2026 г., 23:00 UTC

The EUR/NOK is declining as trading resumes for the week, influenced by ongoing geopolitical tensions in the Middle East and U.S.-Iran relations.

20 сент. 2026 г., 23:00 UTC

The EUR/CHF is slightly lower in early trading this week, reflecting routine fluctuations amid ongoing geopolitical tensions, particularly in the Middle East.

20 сент. 2026 г., 23:00 UTC

The EUR/CZK is slightly lower as trading resumes for the week, reflecting geopolitical tensions affecting financial markets despite remaining near the upper end of its one-month range.

20 сент. 2026 г., 23:00 UTC

Avalanche is experiencing a sharp increase in value, maintaining a position well above its 20-day moving average amid ongoing geopolitical tensions.

20 сент. 2026 г., 22:51 UTC

U.S. 30-Year Mortgage Rate Hits Highest Level Since May at 6.97%, Sparking Concerns Over Housing Demand Amid Rising Treasury Yields and Inflation Fears

20 сент. 2026 г., 22:51 UTC

Chicago Fed National Activity Index Release on September 21, 2026, Anticipates Continued Economic Uncertainty Amid Recent Volatility.

20 сент. 2026 г., 22:11 UTC

UK Consumer Confidence Index Set for Release Amid Mixed Sentiment and Economic Concerns, Forecast at -16.0

20 сент. 2026 г., 22:01 UTC

Correlated Moves

The AUD/USD is slightly lower in early trading, reflecting a cautious investor outlook amid ongoing Middle East conflict and recent interest rate hikes.

20 сент. 2026 г., 22:00 UTC

The EUR/PLN is advancing in early trading, reflecting a notable increase since Friday's close amid ongoing geopolitical tensions and central bank interest rate hikes.

20 сент. 2026 г., 21:21 UTC

Australia's S&P Global Manufacturing PMI Flash set for September 22, with cautious optimism amid global economic pressures.

20 сент. 2026 г., 21:21 UTC

Australia's S&P Global Services PMI Flash set for September 22, with cautious optimism amid global market influences.

20 сент. 2026 г., 21:01 UTC

Brazil's Central Bank to Release Key Market Readout on Interest Rates and Economic Forecasts on September 21, 2026.

20 сент. 2026 г., 20:51 UTC

UK CBI Distributive Trades Forecasts Sharp Decline in Retail Sales Sentiment at -50.0 Amid Ongoing Consumer Spending Downturn

20 сент. 2026 г., 20:21 UTC

UK Factory Orders Show Resilience with Improved Order Book Balance, Yet Forecasts Indicate Continued Decline Amid Economic Challenges.

20 сент. 2026 г., 20:21 UTC

API Crude Oil Stock Change Report on September 22, 2026, Expected to Reveal Rising U.S. Inventories Amid Geopolitical Tensions Impacting Market Sentiment.

20 сент. 2026 г., 19:21 UTC

South Korea's Consumer Confidence Index Release on September 22 Expected to Reflect Cautious Optimism Amid Economic Volatility.

20 сент. 2026 г., 18:51 UTC

Germany's Ifo Business Climate Index set to release with a forecast of 89.2, reflecting cautious optimism amid geopolitical tensions and inflationary pressures.

20 сент. 2026 г., 18:51 UTC

South Africa's Inflation Rate MoM Release on September 23, 2026 Expected to Reflect Global Economic Trends Amid Rising Concerns.

20 сент. 2026 г., 18:51 UTC

South Africa's Inflation Rate Release on September 23, 2026, Expected to Reflect Economic Pressures Amid Rising Costs and Geopolitical Tensions.

20 сент. 2026 г., 18:41 UTC

Cautious Optimism for Euro Area Manufacturing as S&P Global PMI Flash Set to Show Growth at 52.9 Amid Geopolitical Challenges

20 сент. 2026 г., 18:41 UTC

Spain's Balance of Trade Data Set for Release Amidst Ongoing Trade Deficits and Rising Import Costs, Raising Inflation Concerns in the Eurozone.

20 сент. 2026 г., 18:41 UTC

Swiss National Bank Expected to Maintain Zero Interest Rate Amid Subdued Inflation and Modest Economic Growth

20 сент. 2026 г., 18:41 UTC

French Services PMI Flash Expected at 48.5 Amid Political and Economic Concerns, Signaling Continued Contraction

Сравнение c конкурентами

Изменение цены

Aldeyra Therapeutics Inc Прогноз

Целевая цена

By TipRanks

47.06% рост

Прогноз на 12 месяцев

Средняя 2 USD  47.06%

Максимум 2 USD

Минимум 2 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для Aldeyra Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

1 ratings

0

Покупка

1

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Aldeyra Therapeutics Inc

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.